SpyBiotech Email Format

Biotechnology ResearchEngland, United Kingdom11-50 Employees

SpyBiotech is a Oxford-based biotechnology company founded as a spin-out from the University of Oxford in 2017. It develops vaccine technology that attaches antigens to a vaccine scaffold in a single step, aiming to provide a faster and more reliable means of building vaccines. The company operates two complementary platforms: a virus-like particle system that has progressed through early clinical validation and a viral vector approach that extends the same plug-and-play concept to additional targets, collectively forming a flexible engine for vaccines against both established and emerging diseases. Its lead programs address major viral threats, with a cytomegalovirus candidate nearing Phase II readiness after Phase I proof of concept, and an Epstein–Barr virus candidate at Phase I readiness, targeting infections linked to birth defects, certain cancers, and multiple sclerosis.

Get verified SpyBiotech emails free

Company overview Employee directory